Ledger.Open graph →

SEC Form D · filed March 31, 2023

Stingray Therapeutics, Inc

Offering

$5.2M

Sold

$3.9M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

HOUSTON, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Sunil P. Sharma · Houston, TXExec · Director Jonathan P. Northrup · Houston, TXExec · Director Uma P. Bhatt · Houston, TXExec · Director John J. Schreiber · Boston, MAExec · Director Joseph T. Phoenix · Boston, MAExec · Director Philip D. Dreyfuss · San Fransisco, CAExec · Director 325 Capital LLC · NEW YORK, NYExec · Director Uma P. Bhatt · Houston, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗